← Leaderboards
Mark William Tibbitt
Massachusetts Institute Of Technology
$132,632
Attributed
$132,632
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $56.1K · FY2014–17$100K$75K$50K$25K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$132,632 · 1
By mechanism
F32$132,632 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Robert S Langer$47,407,448
- Elazer R Edelman$14,017,661
- Michael J Cima$7,757,125
- Forest M White$24,390,292
- Sibo Lin$162,478
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthFibrosisAnimal ModelFda ApprovedFibrogenesisAreaBackAortic Valve InsufficiencyCollagenBiologicalBiologyDepositionCardiacDisease ProgressionDoseDrug Delivery SystemsClinical TreatmentEffective TherapyEndothelial CellsEngineeringEnvironmentComplicationCytokineHeart
Grant awards (4)
Local delivery of TGF-beta inhibitors to treat mitral valve disease$24,905
F32 · FY2017 · HL · contact PI
Local delivery of TGF-beta inhibitors to treat mitral valve disease$79
F32 · FY2017 · HL · contact PI
Local delivery of TGF-beta inhibitors to treat mitral valve disease$56,118
F32 · FY2016 · HL · contact PI
Local delivery of TGF-beta inhibitors to treat mitral valve disease$51,530
F32 · FY2014 · HL · contact PI